Back
Top 40%
17.5%
Top 3%
8.9%
Top 10%
8.9%
Top 21%
8.9%
Top 2%
6.4%
Top 1%
5.9%
Top 5%
5.0%
Top 8%
5.0%
Top 2%
3.8%
Top 2%
3.0%
Top 6%
2.8%
Top 3%
1.9%
Top 3%
1.9%
Top 1.0%
1.5%
Top 17%
1.3%
Top 0.3%
1.2%
Top 60%
1.2%
Top 16%
0.9%
Top 10%
0.7%
Top 8%
0.7%
Top 6%
0.7%
Top 9%
0.7%
Prognostic Risk Refinement using Artificial Intelligence in HR+/HER2- Early Breast Cancer: Implications for CDK4/6 Eligibility Criteria
2026-01-25
oncology
Title + abstract only
View on medRxiv
Show abstract
Patient selection and enrolment into phase III randomized clinical trials (RCTs) of adjuvant cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor therapies depend on accurate risk definition. However, standard clinicopathologic criteria incompletely capture recurrence risk, limiting their efficacy in treatment selection. To assess whether artificial intelligence (AI)-enhanced prognostication may enrich the clinical risk groups utilized in the adjuvant NATALEE trial, we evaluated Ataraxis Breast RI...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
Cancers
57 training papers
3
Nature Communications
483 training papers
4
Scientific Reports
701 training papers
5
Frontiers in Oncology
34 training papers
6
Clinical Cancer Research
22 training papers
7
npj Digital Medicine
85 training papers
8
eLife
262 training papers
9
British Journal of Cancer
22 training papers
10
Cancer Medicine
17 training papers
11
PLOS Computational Biology
141 training papers
12
BMC Cancer
21 training papers
13
iScience
74 training papers
14
Communications Biology
36 training papers
15
JAMA Network Open
125 training papers
16
Archives of Clinical and Biomedical Research
18 training papers
17
BMJ Open
553 training papers
18
Proceedings of the National Academy of Sciences
100 training papers
19
Computers in Biology and Medicine
39 training papers
20
Communications Medicine
63 training papers
21
Diagnostics
36 training papers
22
PeerJ
46 training papers